title: IGF-1 gene polymorphism in obese patients with insulin resistance.
abstract: IGFs (Insulin like growth factors) are important regulators of pancreatic beta cell development, growth and maintenance. Mutations in the IGF genes have been found to be associated with diabetes mellitus, myocardial infarction obesity. These associations could result from changes in insulin secretion. We aimed to investigate IGF-1 gene polymorphism in obese patients with insulin resistance. We included 100 obese patients with insulin resistance 30 healthy subjects to study. At baseline examinations, antropometric measurements were done. Genomic DNA from the patients and controls were prepared. Thyroid function tests and serum IGFBP3 levels were similar between patients and controls whereas IGF, GH levels were significantly lower in obese patients. We categorized the IGF-1 (CA)19 polymorphism area into 3 groups as lower than 192 bp (group 1), 192-194 bp (group 2), and higher than 194 bp(group 3). Group 3 was more frequent in both obese and control groups. IGF-1 levels were also significantly lower in obese group (138.51 +/- 49.3) in than controls (218.14 +/- 69.15). IGF-1 levels were significantly lower in obese patients. The most frequent IGF-1 gen polymorphism allel is >194 bp in both obese insulin resistant patients and controls. IGF-1 levels and the other biochemical and hormonal parameters were similar in different genotype groups. The cause of lower IGF-1 levels in obese patients might be different from IGF-1 gene polymorphism and it may be insulin resistance.
authors.affiliation: Faculty of Medicine, Department of Endocrinology and Metabolism, Pamukkale University, Kinikli Campus, Denizli, Turkey. guzinf@gmail.com
authors.forename: Guzin
authors.initials: G
authors.lastname: Fidan Yaylali
authors.forename: Fulya
authors.initials: F
authors.lastname: Akin
authors.forename: Sabahat
authors.initials: S
authors.lastname: Turgut
authors.forename: Raziye
authors.initials: R
authors.lastname: Kursunluoglu
mesh_terms: D000328:Adult; D015992:Body Mass Index; D001835:Body Weight / Q000235:genetics; D016022:Case-Control Studies; D005260:Female; D006728:Hormones / Q000097:blood; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics*; D007334:Insulin-Like Growth Factor I / Q000235:genetics*; D008297:Male; D009765:Obesity / Q000097:blood / Q000235:genetics*; D011110:Polymorphism, Genetic
chemical_list: D006728:Hormones; D007334:Insulin-Like Growth Factor I
references.citation: Clin Endocrinol (Oxf). 2004 Aug;61(2):195-203
references.pmid: 15272914
references.citation: Metabolism. 1981 Jan;30(1):89-104
references.pmid: 6780754
references.citation: J Clin Endocrinol Metab. 2000 Apr;85(4):1606-10
references.pmid: 10770205
references.citation: Diabetes Metab. 1996 Jul;22(4):261-7
references.pmid: 8767173
references.citation: Int J Cancer. 2002 Jul 20;100(3):332-6
references.pmid: 12115549
references.citation: J Clin Endocrinol Metab. 1995 Mar;80(3):796-801
references.pmid: 7533771
references.citation: Eur J Endocrinol. 2006 Mar;154(3):379-88
references.pmid: 16498050
references.citation: Diabetes. 2001 Mar;50(3):637-42
references.pmid: 11246885
references.citation: Diabetes. 2002 Jul;51(7):2313-6
references.pmid: 12086966
references.citation: Annu Rev Physiol. 1985;47:443-67
references.pmid: 2986538
references.citation: Growth Horm IGF Res. 2002 Apr;12(2):84-90
references.pmid: 12175645
references.citation: Lancet. 2002 Mar 23;359(9311):1036-7
references.pmid: 11937187
references.citation: Diabetologia. 2004 May;47(5):871-7
references.pmid: 15127203
references.citation: Breast Cancer Res Treat. 2001 Nov;70(2):117-22
references.pmid: 11768601
references.citation: Endocr Rev. 1989 Feb;10(1):68-91
references.pmid: 2666112
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):319-20
references.pmid: 11895885
references.citation: Curr Opin Pharmacol. 2006 Dec;6(6):620-5
references.pmid: 17030015
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825